Previous close | 231.77 |
Open | 231.91 |
Bid | 188.00 x 900 |
Ask | 0.00 x 900 |
Day's range | 229.58 - 237.56 |
52-week range | 167.42 - 261.73 |
Volume | |
Avg. volume | 948,695 |
Market cap | 42.398B |
Beta (5Y monthly) | 1.52 |
PE ratio (TTM) | 31.95 |
EPS (TTM) | 7.29 |
Earnings date | 02 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 276.35 |
Key Insights Using the 2 Stage Free Cash Flow to Equity, IQVIA Holdings fair value estimate is US$332 Current share...
RESEARCH TRIANGLE PARK, N.C., May 02, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2024.
IQVIA Holdings' (IQV) first-quarter 2024 revenues are likely to have benefited from growth in the Technology and Analytics, and Research and Development segments.